On the feasibility of producing Lu-177 in the IEA-R1 reactor via the direct route
Carregando...
Data
Data de publicação
Orientador
Título da Revista
ISSN da Revista
Título do Volume
É parte de
É parte de
É parte de
Brazilian Journal of Radiation Sciences
Exportar
Resumo
Over the last years the 177Lu radioisotope has attracted great interest for the use in therapeutic and diagnostic procedures simultaneously, being what is now called a theranostic radioisotope, with outstanding results in prostate and neuroendocrine cancer. There are mainly two ways of producing this radioisotope, by direct neutron capture in a 176Lu target (the “direct route") or by irradiating a 176Yb sample, producing 177Yb that will then decay to 177Lu (also referred as the “indirect route”). In this work, the technical feasibility of producing 177Lu in the IEA-R1 nuclear research reactor via the direct route was assessed, and the specific activity that could be obtained was estimated both experimentally and theoretically.
Como referenciar
ZAHN, G.S.; GENEZINI, F.A.; SILVA, P.S.C.; NORY, R.M.; MOREIRA, E.G.; SANTIAGO, P.S. On the feasibility of producing Lu-177 in the IEA-R1 reactor via the direct route. Brazilian Journal of Radiation Sciences, v. 9, n. 1A, p. 1-11, 2021. DOI: 10.15392/bjrs.v9i1A.1411. Disponível em: http://repositorio.ipen.br/handle/123456789/32111. Acesso em: 27 Mar 2026.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.